News:

  3. Paxlovid Lowers Long-Term Stroke and Death Risk in COVID Patients, confirms study

Advertise Here
+-+-

User+-

Welcome, Guest.
Please login or register.
 
 
 
Forgot your password?
« previous next »
Pages: [1]

Author Topic: Paxlovid Lowers Long-Term Stroke and Death Risk in COVID Patients, confirms study  (Read 1773 times)

0 Members and 49 Guests are viewing this topic.

Paxlovid Lowers Long-Term Stroke and Death Risk in COVID Patients, confirms study
« on: »
Paxlovid Lowers Long-Term Stroke and Death Risk in COVID Patients, confirms study.

This study was published on May 13th, 2025.

Source of information.

1. Medical Dialogues.

Paxlovid Lowers Long-Term Stroke and Death Risk in COVID Patients, confirms study
Researchers have discovered in a new study that using Paxlovid (nirmatrelvir/ritonavir) early in the course of mild-to-moderate COVID-19 can substantially lower the long-term risk of stroke and...
medicaldialogues.in
Logged

Share on Bluesky Share on Facebook

Pages: [1]
« previous next »
  3. Paxlovid Lowers Long-Term Stroke and Death Risk in COVID Patients, confirms study
 


Advertise Here